XS
XR Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-672
| Closed | -$706K | – | 77 |
|
|
2024
Q3 | $706K | Buy |
672
+20
| +3% | +$21K | 0.21% | 5 |
|
|
2024
Q2 | $685K | Sell |
652
-229
| -26% | -$241K | 0.13% | 23 |
|
|
2024
Q1 | $848K | Sell |
881
-3,126
| -78% | -$3.01M | 0.03% | 27 |
|
|
2023
Q4 | $3.52M | Buy |
4,007
+3,584
| +847% | +$3.15M | 0.13% | 5 |
|
|
2023
Q3 | $348K | Buy |
+423
| New | +$348K | 0.03% | 38 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 187 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 244 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 253 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 229 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 192 |
|
|
2020
Q2 | – | Sell |
-426
| Closed | -$208K | – | 197 |
|
|
2020
Q1 | $208K | Buy |
+426
| New | +$208K | 0.02% | 77 |
|
|
2019
Q3 | – | Sell |
-2,255
| Closed | -$706K | – | 190 |
|
|
2019
Q2 | $706K | Buy |
2,255
+1,299
| +136% | +$407K | 0.14% | 36 |
|
|
2019
Q1 | $393K | Buy |
+956
| New | +$393K | 0.05% | 77 |
|